Multiplikator Forward P/S: SmartVest (ELMD)
Electromed, Inc. (ELMD) is developing the SmartVest digital environment for lung therapy, while direct system sales are enhancing margins. The forward P/S dynamics for the company clearly demonstrate market revenue expectations, where the indicator value is 2.30. Investors can derive a real-time valuation of the business based on its leadership in airway clearance and the absolute trust of COPD patients.
Ringkesan rincian data analitis smartvest.com (ELMD)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Electromed, Inc.|ELMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Electromed|ELMD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ELMD|ELMD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Electromed, Inc.|Rasio cepet smartvest.com
- rincian asil keuangan lan kelipatan valuasi:
ELMD - Penghasilan resik perusahaan|Bathi sing dikarepake Electromed, Inc.|ELMD - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Electromed|ELMD - Pangali PEG|Pangali EV/EBITDA ELMD|ELMD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Electromed, Inc.|ELMD - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan smartvest.com|ELMD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Electromed, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:ELMD (Electromed Inc)
For Electromed, Inc. (ELMD), this indicator serves as a gauge of market expectations regarding sales growth rates for therapeutic equipment amid a dependence on Medicare insurance payments. By analyzing the company's projected P/S ratio, an investor compares current market capitalization with forecasted revenue, allowing for an assessment of the asset's overbought status and the risks of a correction should planned sales targets in this narrow niche not be achieved.
Karo sapa Electromed, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep profusa.com (PFSA)|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|Rasio rega marang prakiraan pendapatan GCTK|Multiplikator Forward P/S NAOV|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD - Multiplikator forward rega marang pendapatan|ASXC: Multiplikator forward rega marang pendapatan|Avinger Inc. - Rasio rega marang pendapatan sing dikarepake|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Cutera Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep inarimedical.com NARI|Rasio rega marang prakiraan pendapatan Nevro (NVRO)|Multiplikator forward rega marang pendapatan reshapelifesciences.com RSLS|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
